From: Effect of Pollen-Specific Sublingual Immunotherapy on Oral Allergy Syndrome: An Observational Study
Patients Treated With SLIT | n = 102 |
---|---|
Median age, yrs (range) | 34.5 (6-64) |
Children < 14 yrs, % | 13.7 |
Male/female, % | 33.3/66.7 |
Median duration of rhinoconjunctivitis, yrs (range) | 8.0 (1-37) |
Patients with pollen-induced airway symptoms, % | 62.7 |
Patients with pollen-induced skin symptoms, % | 23.5 |
Positive skin prick test to: | n (%) |
Grasses and rye | 63 (67.7) |
Birch, alder, hazel | 93 (93.9) |
Beech, oak, ash | 35 (50.7) |
Mugwort | 26 (34.2) |
Other pollen | 5 (12.8) |
House dust mites | 27 (34.2) |
Animal dander | 22 (31.0) |
SLIT treatment with (includes multiple entries): | n (%) |
Tree mix (birch, alder, hazel) | 81 (79.4) |
Grasses and rye | 38 (37.3) |
Mugwort | 6 (5.9) |
OAS history | |
Patients evaluable | n = 99 |
Median duration of OAS, yrs (range) | 5.0 (0-23) |
Predominant triggers, % | |
Apple | 81.8 |
Hazelnut | 73.7 |
Carrot | 27.3 |
Predominant symptoms | OAS reactions with this symptom, % |
Itchy lips, tongue, and/or oral mucosa | 83.4 |
Swelling of lips, tongue, oral mucosa, and/or larynx | 74.3 |
Burning of tongue | 40.0 |
Eye symptoms | 34.9 |
Nose symptoms | 32.6 |